Mechanistically, the alteration of microbial community after RS supplement increased the levels of intestinal short-chain fatty acids (SCFAs), especially butyrate, leading to the suppression of glycolysis and CRC cell proliferation by downregulating HK2. The gene discussed is HK2; the disease is colorectal carcinoma.